Shop Talk : Oncology Times
An abstract is unavailable.
An abstract is unavailable.
Over the past three years, the American Cancer Society has recovered from the fundraising decline brought on by COVID-19 and has reversed the years-long fundraising…
TAR-200 displayed a high complete response rate in Bacillus Calmette–Guérin-unresponsive high-risk non–muscle-invasive bladder cancer.
Acalabrutinib plus bendamustine and rituximab bettered progression-free survival over bendamustine and rituximab alone in patients with untreated mantle cell lymphoma.
Administering high-intensity focused ultrasound could be a noninferior treatment option for patients with localized prostate cancer, according to a prospective trial.
creasingly evident that to develop research that is both meaningful to people who have the targeted condition and is feasible, there are important benefits of…
Join us for an exciting discussion where expert oncologists in the field of colorectal cancer will deliberate on nuances related to sequencing oral tyrosine kinase…
That year, Hill Day brought about 60 ASCO members to Capitol Hill. This year’s event saw more than 170 members visiting the halls of several…
High-intensity focused ultrasound produced noninferior salvage treatment-free survival vs radical prostatectomy in localized prostate cancer.
Investigators established a fluorescence in situ hybridization assay to measure NECTIN4 copy number variations and found that NECTIN4 amplification was associated with high activity of…
2024 SNO/ASCO Metastases August 8-10, 2024, Denver, CO